Trials / Withdrawn
WithdrawnNCT03377595
Post C-Section Pain Control Using EXPAREL
Post-cesarean Section Analgesic Safety and Efficacy of EXPAREL (Liposomal Bupivacaine) Infiltration Locally Versus Transversus Abdominis Plane Infiltration
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Minnesota · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Evaluating the safety and efficacy of EXPAREL (Liposomal Bupivacaine ) for pain control in patients undergoing scheduled cesarean section by giving it either as infiltration in Transversus Abdominis Plane after finishing the procedure or through wound infiltration into the fascia prior to closure of skin
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Exparel | TAP (Transversus Abdominis Plane) block |
| DRUG | Exparel | Wound infiltration |
Timeline
- Start date
- 2019-07-02
- Primary completion
- 2019-08-30
- Completion
- 2019-09-01
- First posted
- 2017-12-19
- Last updated
- 2021-05-18
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03377595. Inclusion in this directory is not an endorsement.